X

Xyphos Biosciences

6 employees

Xyphos Biosciences develops a CAR-T cell therapy platform for treating relapsed hematological malignancies and solid tumors.

Basic info

Industry

biotechnology

Sectors

Biotechnology

Health Care

Medical

Date founded

2017

FAQ